IL10 and breast carcinoma: Our results regarding IFNG and IL10 expression should be considered merely exploratory, and other experimental approaches, such as detailed cytometry of functional subpopulations [44] or immune mediators expression arrays [42], are warranted to obtain further insights on the clinical relevance of breast cancer immune balance.